Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00200538 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Efficacy and Tolerability of Memantine in Frontotemporal Dementia (FTD) Patients

StatusCompleted
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Publications: details revised at 1 of 2 entriesv8
  2. Enrollment target: estimated 64 to confirmed 52v7
  3. Trial status: Recruiting to Completed Site details revisedv6 Show all 2 changesShow less
    • Site details revised
  4. Eligibility criteria revised Study description revisedv5 Show all 2 changesShow less
    • Study description revised

    See this version in full on ClinicalTrials.gov ↗

  5. Study description shortened, about 13 words Site contact updated · Study title shortened, about 9 words · Eligibility criteria shortened, about 1 wordv4 Show all 4 changesShow less
    • Site contact updated
    • Study title shortened, about 9 words
    • Eligibility criteria shortened, about 1 word

    See this version in full on ClinicalTrials.gov ↗

Show 2 earlier versionsHide 2 earlier versions
  1. Phase: Phase 4 to Phase 2 Interventions: mementine (Drug) to memantine (Drug) · Site contact updatedv3 Show all 3 changesShow less
    • Interventions: mementine (Drug) to memantine (Drug)
    • Site contact updated
  2. Phase: Phase 2 to Phase 4 Trial status: Not Yet Recruiting to Recruiting · Start date: Sep 2005 · Site details revisedv2 Show all 4 changesShow less
    • Trial status: Not Yet Recruiting to Recruiting
    • Start date: Sep 2005
    • Site details revised
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this trial is to assess the efficacy and tolerability of memantine (anti-excitotoxic, neuroprotective treatment currently used in Alzheimer's disease \[AD\]) in frontotemporal dementia patients after a one-year treatment.
Trial Details
NCT Number NCT00200538
Lead Sponsor Nantes University Hospital
Conditions Dementia
Enrollment 52 participants
Start Date
Updated on ClinicalTrials.gov